Last update 01 Nov 2024

αvβ3 x CDK9 x cyclin-T1

Basic Info

Related Targets
αvβ3CDK9cyclin-T1

Related

1
Drugs associated with αvβ3 x CDK9 x cyclin-T1
VIP-280
Target
CDK9 x cyclin-T1 x αvβ3
Mechanism
CDK9 inhibitors [+2]
Active Org.
Vincerx Pharma, Inc.Vincerx Pharma, Inc.
Originator Org.
Vincerx Pharma, Inc.Vincerx Pharma, Inc.
Active Indication
Neoplasms
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
100 Clinical Results associated with αvβ3 x CDK9 x cyclin-T1
Login to view more data
100 Translational Medicine associated with αvβ3 x CDK9 x cyclin-T1
Login to view more data
0 Patents (Medical) associated with αvβ3 x CDK9 x cyclin-T1
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free